📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
0 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
NEUTRAL
TOTAL VIEWS
50
TNXP Latest News & AI Sentiment Analysis
0 articles · Grade: NEUTRAL · Real-time AI-graded coverage
RECENT COVERAGE · 4 ARTICLES
TNXP Initiates Coverage by Canaccord Genuity -- Rating Set to Buy
TNXP received initial coverage from Canaccord Genuity with a Buy rating, marking an analyst entry point rather than a fundamental...
Tonix Pharmaceuticals Holding Corp. (TNXP) Q2 2026 Earnings Call Transcript
This article is a scheduled earnings call transcript for Tonix Pharmaceuticals (TNXP) conducted on August 10, 2026. As a procedural...
Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights
TNXP released Q2 2026 earnings showing TONMYA® net sales of approximately $11 million, representing a 197% quarter-over-quarter...
Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences
Tonix Pharmaceuticals (TNXP) announced participation in two investor conferences scheduled for August and September 2026, with...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice